| Name | Title | Contact Details |
|---|
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
CCS Assoc is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aatru Medical, LLC (Aatru) is a privately-held medical device company specializing in technology development in negative pressure wound therapy for surgical incisions and chronic wounds. The Aatru NPSIMS™ represents a new and advanced technology in ultraportable devices that are designed for use on closed surgical incisions that produce low exudate.
Freedom Health, Inc. is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
For people with life-threatening blood cancers like leukemia and lymphoma or other diseases, a cure exists. Be The Match connects patients with their donor match for a life-saving marrow or umbilical cord blood transplant. Every year, thousands of men, women and children get life-threatening diseases like leukemia and lymphoma. Many of them will die unless they get a bone marrow or cord blood transplant from a genetically matched donor. Some people find a match in their family, but 70% do not. These patients depend on the Be The Match to help them find an unrelated donor or cord blood unit. Whether you want to swab your cheek and join Be The Match Registry, make a financial gift or download a photo to show your support on Facebook, you’re in the right place. The best part? Every action you take helps. Be The Match, operated by National Marrow Donor Program (NMDP), is a nonprofit organization dedicated to creating an opportunity for all patients to receive the marrow or umbilical cord blood transplant they need, when they need it.